Comment on CMS-2026-1916-0001

Summary: Tobii Dynavox, a manufacturer of speech-generating devices (SGDs), opposes the proposed rule because it may limit state flexibility and increase administrative costs, potentially leading to restricted access to medically necessary communication equipment. The company argues that the proposed changes could force states to tighten coverage criteria and increase prior authorization barriers for high-need, low-volume durable medical equipment.